;PMID: 11464866
;source_file_2996.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..41] = [t:0..41]
;1)sentence:[e:47..137] = [t:47..137]
;2)section:[e:141..196] = [t:141..196]
;3)section:[e:200..291] = [t:200..291]
;4)sentence:[e:295..541] = [t:295..541]
;5)sentence:[e:542..653] = [t:542..653]
;6)sentence:[e:654..798] = [t:654..798]
;7)sentence:[e:799..965] = [t:799..965]
;8)sentence:[e:966..1129] = [t:966..1129]
;9)sentence:[e:1131..1413] = [t:1131..1413]
;10)sentence:[e:1414..1523] = [t:1414..1523]
;11)section:[e:1527..1572] = [t:1527..1572]

;section 0 Span:0..41
;Med Pediatr Oncol.  2001 Jan;36(1):135-8.
(SEC
  (FRAG (NNP:[0..3] Med) (NNP:[4..11] Pediatr) (NNP:[12..17] Oncol)
        (.:[17..18] .) (CD:[20..24] 2001) (NNP:[25..28] Jan) (::[28..29] ;)
        (CD:[29..31] 36) (-LRB-:[31..32] -LRB-) (CD:[32..33] 1)
        (-RRB-:[33..34] -RRB-) (::[34..35] :) (CD:[35..40] 135-8) (.:[40..41] .)))

;sentence 1 Span:47..137
;Differential gene regulation by 9-cis and all-trans retinoic acid in 
;neuroblastoma cells.
;[117..130]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP (JJ:[47..59] Differential) (NN:[60..64] gene) (NN:[65..75] regulation))
    (PP (IN:[76..78] by)
      (NP
        (NP (NN:[79..84] 9-cis))
        (CC:[85..88] and)
        (NP
          (ADJP (RB:[89..92] all) (HYPH:[92..93] -) (JJ:[93..98] trans))
          (JJ:[99..107] retinoic) (NN:[108..112] acid))))
    (PP-LOC (IN:[113..115] in)
      (NP (NN:[117..130] neuroblastoma) (NNS:[131..136] cells)))
    (.:[136..137] .)))

;section 2 Span:141..196
;Lovat PE, Dobson M, Malcolm AJ, Pearson AD, Redfern CP.
(SEC
  (FRAG (NNP:[141..146] Lovat) (NNP:[147..149] PE) (,:[149..150] ,)
        (NNP:[151..157] Dobson) (NNP:[158..159] M) (,:[159..160] ,)
        (NNP:[161..168] Malcolm) (NNP:[169..171] AJ) (,:[171..172] ,)
        (NNP:[173..180] Pearson) (NNP:[181..183] AD) (,:[183..184] ,)
        (NNP:[185..192] Redfern) (NN:[193..195] CP) (.:[195..196] .)))

;section 3 Span:200..291
;Department of Medicine, Medical School, University of Newcastle Upon Tyne, 
;United Kingdom.
(SEC
  (FRAG (NNP:[200..210] Department) (IN:[211..213] of) (NNP:[214..222] Medicine)
        (,:[222..223] ,) (NNP:[224..231] Medical) (NNP:[232..238] School)
        (,:[238..239] ,) (NNP:[240..250] University) (IN:[251..253] of)
        (NNP:[254..263] Newcastle) (NNP:[264..268] Upon) (NNP:[269..273] Tyne)
        (,:[273..274] ,) (NNP:[276..282] United) (NNP:[283..290] Kingdom)
        (.:[290..291] .)))

;sentence 4 Span:295..541
;BACKGROUND: 9-cis retinoic acid (RA) is more effective than all-trans RA at 
;inducing neuroblastoma differentiation in vitro, and has distinct biological 
;properties with respect to its ability to promote apoptosis in N-type 
;neuroblastoma cells.
;[381..394]:malignancy-type:"neuroblastoma"
;[521..534]:malignancy-type:"neuroblastoma"
(SENT
  (NP (NN:[295..305] BACKGROUND) (::[305..306] :))
  (S
    (NP-SBJ
      (NP (NN:[307..312] 9-cis) (JJ:[313..321] retinoic) (NN:[322..326] acid))
      (NP (-LRB-:[327..328] -LRB-) (NN:[328..330] RA) (-RRB-:[330..331] -RRB-)))
    (VP
      (VP (VBZ:[332..334] is)
        (ADJP-PRD
          (ADJP (RBR:[335..339] more) (JJ:[340..349] effective))
          (PP (IN:[350..354] than)
            (NP
              (ADJP (RB:[355..358] all) (HYPH:[358..359] -)
                    (JJ:[359..364] trans))
              (NN:[365..367] RA))))
        (PP (IN:[368..370] at)
          (S-NOM
            (NP-SBJ (-NONE-:[370..370] *))
            (VP (VBG:[372..380] inducing)
              (NP (NN:[381..394] neuroblastoma) (NN:[395..410] differentiation))
              (ADVP (FW:[411..413] in) (FW:[414..419] vitro))))))
      (,:[419..420] ,) (CC:[421..424] and)
      (VP (VBZ:[425..428] has)
        (NP
          (NP (JJ:[429..437] distinct) (JJ:[438..448] biological)
              (NNS:[450..460] properties))
          (PP (IN:[461..465] with)
            (NP
              (NP (NN:[466..473] respect))
              (PP (TO:[474..476] to)
                (NP (PRP$:[477..480] its) (NN:[481..488] ability)
                  (S
                    (NP-SBJ (-NONE-:[488..488] *))
                    (VP (TO:[489..491] to)
                      (VP (VB:[492..499] promote)
                        (NP (NN:[500..509] apoptosis))
                        (PP-LOC (IN:[510..512] in)
                          (NP (NN:[513..519] N-type)
                              (NN:[521..534] neuroblastoma)
                              (NNS:[535..540] cells)))))))))))))
    (.:[540..541] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[295..541]::NP:S:

;sentence 5 Span:542..653
;The cellular effects of 9-cis RA may, in part, result from  activation of
;retinoid X receptor (RXR) homodimers.
;[616..635]:gene-protein:"retinoid X receptor"
;[637..640]:gene-protein:"RXR"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[542..545] The) (JJ:[546..554] cellular) (NNS:[555..562] effects))
      (PP (IN:[563..565] of)
        (NP (NN:[566..571] 9-cis) (NN:[572..574] RA))))
    (VP (MD:[575..578] may) (,:[578..579] ,)
      (PP (IN:[580..582] in)
        (NP (NN:[583..587] part)))
      (,:[587..588] ,)
      (VP (VBP:[589..595] result)
        (PP (IN:[596..600] from)
          (NP
            (NP (NN:[602..612] activation))
            (PP (IN:[613..615] of)
              (NP
                (NML (JJ:[616..624] retinoid) (NN:[625..626] X)
                     (NN:[627..635] receptor))
                (NML
                  (NML (-LRB-:[636..637] -LRB-) (NN:[637..640] RXR)
                       (-RRB-:[640..641] -RRB-)))
                (NNS:[642..652] homodimers)))))))
    (.:[652..653] .)))

;sentence 6 Span:654..798
;If this hypothesis is  correct, 9-cis RA may control the expression of a
;different subset of  retinoid-regulated genes compared to all-trans RA.
(SENT
  (S
    (SBAR-ADV (IN:[654..656] If)
      (S
        (NP-SBJ (DT:[657..661] this) (NN:[662..672] hypothesis))
        (VP (VBZ:[673..675] is)
          (ADJP-PRD (JJ:[677..684] correct)))))
    (,:[684..685] ,)
    (NP-SBJ (NN:[686..691] 9-cis) (NN:[692..694] RA))
    (VP (MD:[695..698] may)
      (VP (VB:[699..706] control)
        (NP
          (NP (DT:[707..710] the) (NN:[711..721] expression))
          (PP (IN:[722..724] of)
            (NP
              (NP
                (NP (DT:[725..726] a) (JJ:[727..736] different)
                    (NN:[737..743] subset))
                (PP (IN:[744..746] of)
                  (NP
                    (ADJP (NN:[748..756] retinoid) (HYPH:[756..757] -)
                          (VBN:[757..766] regulated))
                    (NNS:[767..772] genes))))
              (VP (VBN:[773..781] compared)
                (NP (-NONE-:[781..781] *))
                (PP (TO:[782..784] to)
                  (NP
                    (ADJP (RB:[785..788] all) (HYPH:[788..789] -)
                          (JJ:[789..794] trans))
                    (NN:[795..797] RA)))))))))
    (.:[797..798] .)))

;sentence 7 Span:799..965
;PROCEDURE: We have therefore  used differential mRNA display to identify
;genes differentially expressed in  neuroblastoma cells in response to
;all-trans and 9-cis RA.
;[907..920]:malignancy-type:"neuroblastoma"
(SENT
  (NP (NN:[799..808] PROCEDURE) (::[808..809] :))
  (S
    (NP-SBJ (PRP:[810..812] We))
    (VP (VBP:[813..817] have)
      (ADVP (RB:[818..827] therefore))
      (VP (VBN:[829..833] used)
        (NP (JJ:[834..846] differential) (NN:[847..851] mRNA)
            (NN:[852..859] display))
        (S-PRP
          (NP-SBJ (-NONE-:[859..859] *))
          (VP (TO:[860..862] to)
            (VP (VB:[863..871] identify)
              (NP
                (NP (NNS:[872..877] genes))
                (VP
                  (ADVP (RB:[878..892] differentially))
                  (VBN:[893..902] expressed)
                  (NP (-NONE-:[902..902] *))
                  (PP-LOC (IN:[903..905] in)
                    (NP (NN:[907..920] neuroblastoma) (NNS:[921..926] cells)))
                  (PP (IN:[927..929] in)
                    (NP
                      (NP (NN:[930..938] response))
                      (PP (TO:[939..941] to)
                        (NP
                          (NP
                            (ADJP (RB:[942..945] all) (HYPH:[945..946] -)
                                  (JJ:[946..951] trans)))
                          (CC:[952..955] and)
                          (NP (NN:[956..961] 9-cis) (NN:[962..964] RA)))))))))))))
    (.:[964..965] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[799..965]::NP:S:

;sentence 8 Span:966..1129
;RESULTS: The majority  of cDNAs differentially expressed in response to
;all-trans or 9-cis RA matched  to nonredundant Genbank sequences or EST
;database sequences.
(SENT
  (NP (NNS:[966..973] RESULTS) (::[973..974] :))
  (S
    (NP-SBJ
      (NP (DT:[975..978] The) (NN:[979..987] majority))
      (PP (IN:[989..991] of)
        (NP
          (NP (NNS:[992..997] cDNAs))
          (VP
            (ADVP (RB:[998..1012] differentially))
            (VBN:[1013..1022] expressed)
            (NP (-NONE-:[1022..1022] *))
            (PP (IN:[1023..1025] in)
              (NP
                (NP (NN:[1026..1034] response))
                (PP (TO:[1035..1037] to)
                  (NP
                    (NP
                      (ADJP (RB:[1038..1041] all) (HYPH:[1041..1042] -)
                            (JJ:[1042..1047] trans)))
                    (CC:[1048..1050] or)
                    (NP (NN:[1051..1056] 9-cis) (NN:[1057..1059] RA))))))))))
    (VP (VBD:[1060..1067] matched)
      (PP (TO:[1069..1071] to)
        (NP
          (NP (JJ:[1072..1084] nonredundant) (NN:[1085..1092] Genbank)
              (NNS:[1093..1102] sequences))
          (CC:[1103..1105] or)
          (NP (NN:[1106..1109] EST) (NN:[1110..1118] database)
              (NNS:[1119..1128] sequences)))))
    (.:[1128..1129] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[966..1129]::NP:S:

;sentence 9 Span:1131..1413
;Differential-display profiles were similar in SH SY 5Y and SH S EP cells,
;clonal  derivatives of the mixed neuroblastoma cell line SK N SH, although
;there were  apparent differences between these cell lines with respect to the
; retinoid-regulation of specific RT-PCR cDNA fragments.
;[1238..1251]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ
      (NML (JJ:[1131..1143] Differential) (HYPH:[1143..1144] -)
           (NN:[1144..1151] display))
      (NNS:[1152..1160] profiles))
    (VP (VBD:[1161..1165] were)
      (ADJP-PRD (JJ:[1166..1173] similar))
      (PP (IN:[1174..1176] in)
        (NP
          (NP
            (NP (NN:[1177..1179] SH) (NN:[1180..1182] SY) (NN:[1183..1185] 5Y)
              (NML-1 (-NONE-:[1185..1185] *P*)))
            (CC:[1186..1189] and)
            (NP (NN:[1190..1192] SH) (NN:[1193..1194] S) (NN:[1195..1197] EP)
              (NML-1 (NNS:[1198..1203] cells))))
          (,:[1203..1204] ,)
          (NP
            (NP (JJ:[1205..1211] clonal) (NNS:[1213..1224] derivatives))
            (PP (IN:[1225..1227] of)
              (NP
                (NP (DT:[1228..1231] the) (VBN:[1232..1237] mixed)
                    (NN:[1238..1251] neuroblastoma) (NN:[1252..1256] cell)
                    (NN:[1257..1261] line))
                (NP (NN:[1262..1264] SK) (NN:[1265..1266] N)
                    (NN:[1267..1269] SH)))))))
      (,:[1269..1270] ,)
      (SBAR-ADV (IN:[1271..1279] although)
        (S
          (NP-SBJ (EX:[1280..1285] there))
          (VP (VBD:[1286..1290] were)
            (NP-PRD
              (NP (JJ:[1292..1300] apparent) (NNS:[1301..1312] differences))
              (PP (IN:[1313..1320] between)
                (NP (DT:[1321..1326] these) (NN:[1327..1331] cell)
                    (NNS:[1332..1337] lines))))
            (PP (IN:[1338..1342] with)
              (NP
                (NP (NN:[1343..1350] respect))
                (PP (TO:[1351..1353] to)
                  (NP
                    (NP (DT:[1354..1357] the) (NN:[1359..1367] retinoid)
                        (HYPH:[1367..1368] -) (NN:[1368..1378] regulation))
                    (PP (IN:[1379..1381] of)
                      (NP (JJ:[1382..1390] specific)
                        (NML (NN:[1391..1393] RT) (HYPH:[1393..1394] -)
                             (NN:[1394..1397] PCR))
                        (NN:[1398..1402] cDNA) (NNS:[1403..1412] fragments)))))))))))
    (.:[1412..1413] .)))

;sentence 10 Span:1414..1523
;CONCLUSIONS: These data  support the view that 9-cis and all-trans RA act via
;different receptor  mechanisms.
(SENT
  (NP (NNS:[1414..1425] CONCLUSIONS) (::[1425..1426] :))
  (S
    (NP-SBJ (DT:[1427..1432] These) (NNS:[1433..1437] data))
    (VP (VBP:[1439..1446] support)
      (NP (DT:[1447..1450] the) (NN:[1451..1455] view)
        (SBAR (IN:[1456..1460] that)
          (S
            (NP-SBJ
              (NP (NN:[1461..1466] 9-cis))
              (CC:[1467..1470] and)
              (NP
                (ADJP (RB:[1471..1474] all) (HYPH:[1474..1475] -)
                      (JJ:[1475..1480] trans))
                (NN:[1481..1483] RA)))
            (VP (VBP:[1484..1487] act)
              (PP (IN:[1488..1491] via)
                (NP (JJ:[1492..1501] different) (NN:[1502..1510] receptor)
                    (NNS:[1512..1522] mechanisms))))))))
    (.:[1522..1523] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[1414..1523]::NP:S:

;section 11 Span:1527..1572
;PMID: 11464866 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1527..1531] PMID) (::[1531..1532] :) (CD:[1533..1541] 11464866)
        (NN:[1542..1543] -LSB-) (NNP:[1543..1549] PubMed) (::[1550..1551] -)
        (NN:[1552..1559] indexed) (IN:[1560..1563] for)
        (NNP:[1564..1571] MEDLINE) (-RRB-:[1571..1572] -RSB-)))
